Epidemiology and costs of herpes zoster: Background data to estimate the impact of vaccination
| Autor: | Di_legami, V, Gianino, M, Ciofi_degli_atti, M, Massari, M, Migliardi, A, SCALIA TOMBA, G, Zotti, C, Zoster_study_group |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Pediatrics medicine.medical_specialty Adolescent Cost-Benefit Analysis Population Herpes Zoster Mass Vaccination Cost of Illness Epidemiology Herpes Zoster Vaccine Humans Medicine education Aged education.field_of_study General Veterinary General Immunology and Microbiology biology Cost–benefit analysis Immunization Programs business.industry Incidence Incidence (epidemiology) Vaccination Background data Public Health Environmental and Occupational Health Euros Middle Aged biology.organism_classification Settore MAT/06 - Probabilita' e Statistica Matematica Hospitalization Regional hospital Infectious Diseases Italy Molecular Medicine business |
| Zdroj: | Vaccine. 25:7598-7604 |
| ISSN: | 0264-410X |
| DOI: | 10.1016/j.vaccine.2007.07.049 |
| Popis: | In 2004, we conducted a study in Piemonte (Italy), in order to describe incidence, treatment, hospitalizations and costs of herpes zoster (HZ), in population over 14 years of age. Twenty-four regional general practitioners, with 26,394 patients >14 years in charge (0.71% of the regional population), reported prospectively all diagnosed HZ cases. In addition, all regional hospital discharge records were reviewed. Forty-six HZ cases treated at home were reported, accounting for a total incidence of 1.74 cases/1000 population >14 years per year. HZ rate standardized by age on regional population 14 years older is 1.59/1000. The cost per observed home case was 136.06 euros. The incidence of hospital admissions was 0.12/1000 inhabitants. The mean cost of hospitalized cases was 4082.59 euros. These results contribute to depict the impact of HZ in the general population, and to provide background data for setting-up either mathematical models aimed to estimate the impact of vaccination on HZ, and the cost-benefit analyses of various preventive and therapeutic scenarios. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect